Department of Pathology, JSSAHER, India
Case Report
Rifampicin Induced Pigment Nephropathy-A Rare Case Report
Author(s): Shetty M, Chetan CS*, Prasad S, Kiran KK, Manoj C, Shastry V, Ranugha PSS and Suchitha S
Introduction: Rifampicin is one of the first lines drugs and forms the backbone for the treatment of Tuberculosis and Hansen s disease. Although decreasing in Incidence and prevalence, India still has a high burden of both the diseases necessitating the use of Rifampicin. Major adverse effects of Rifampicin are rare and renal involvement is even rare.
Case report: We report a Thirty-Seven-year-old lady who was on DOT therapy for Borderline Tuberculoid Leprosy (BT) presenting with rapidl.. View More»
DOI:
10.35248/2472-1220.20.6.178
